A comparison of strategies to stabilize immunoglobulin Fv-fragments
- PMID: 2110478
- DOI: 10.1021/bi00458a002
A comparison of strategies to stabilize immunoglobulin Fv-fragments
Abstract
Fv-Fragments of antibodies may dissociate at low protein concentrations and are too unstable for many applications at physiological temperatures. To stabilize Fv-fragments against dissociation, we have tested and compared three different strategies on the Fv-fragment of the well-characterized phosphocholine binding antibody McPC603 expressed and secreted in Escherichia coli: chemical cross-linking of the variable domains, introduction of an intermolecular disulfide bond, and construction of a peptide linker to produce a "single-chain" Fv-fragment. All the linked fragments show hapten affinities nearly identical with that of the whole antibody independent of protein concentration and are significantly (up to 60-fold) stabilized against irreversible thermal denaturation. All genetically engineered linked Fv-fragments can be obtained in native conformation in E. coli. The reported strategies for generating Fv-fragments with improved physicochemical properties may extend their usefulness in biotechnology as well as in therapeutic and diagnostic applications.
Similar articles
-
Properties of FV and Fab fragments of the antibody McPC603 expressed in E. coli.Behring Inst Mitt. 1990 Dec;(87):48-55. Behring Inst Mitt. 1990. PMID: 2096820
-
Assembly of a functional immunoglobulin Fv fragment in Escherichia coli.Science. 1988 May 20;240(4855):1038-41. doi: 10.1126/science.3285470. Science. 1988. PMID: 3285470
-
The disulfide bonds in antibody variable domains: effects on stability, folding in vitro, and functional expression in Escherichia coli.Biochemistry. 1992 Feb 11;31(5):1270-9. doi: 10.1021/bi00120a002. Biochemistry. 1992. PMID: 1736986
-
Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments.Nat Biotechnol. 1996 Oct;14(10):1239-45. doi: 10.1038/nbt1096-1239. Nat Biotechnol. 1996. PMID: 9631086 Review.
-
Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxins.Clin Cancer Res. 1996 Feb;2(2):245-52. Clin Cancer Res. 1996. PMID: 9816166 Review.
Cited by
-
Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing.Protein Eng Des Sel. 2012 Oct;25(10):571-80. doi: 10.1093/protein/gzs064. Epub 2012 Sep 13. Protein Eng Des Sel. 2012. PMID: 22976197 Free PMC article.
-
Construction and Periplasmic Expression of the Anti-EGFRvIII ScFv Antibody Gene in Escherichia coli.Sci Pharm. 2016 Feb 14;84(1):141-52. doi: 10.3797/scipharm.ISP.2015.06. Print 2016 Jan-Mar. Sci Pharm. 2016. PMID: 27110505 Free PMC article.
-
The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi.Microb Cell Fact. 2003 Jan 30;2(1):1. doi: 10.1186/1475-2859-2-1. Microb Cell Fact. 2003. PMID: 12605725 Free PMC article.
-
Bacterial expression and refolding of single-chain Fv fragments with C-terminal cysteines.Cell Biophys. 1995 Jun;26(3):187-204. doi: 10.1007/BF02791580. Cell Biophys. 1995. PMID: 8521451
-
Discovery Strategies to Maximize the Clinical Potential of T-Cell Engaging Antibodies for the Treatment of Solid Tumors.Antibodies (Basel). 2020 Nov 18;9(4):65. doi: 10.3390/antib9040065. Antibodies (Basel). 2020. PMID: 33217946 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources